Primary Obstructive Megaureter Management in Eastern Interregional Area
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Nov 28, 2022
Trial Information
Current as of January 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minor patient (from 1 to 17 years old)
- • Patient treated between January 2010 and December 2017 in one of the participating centers for an obstructive congenital mega-ureter
- • Subject (and/or his parental authority) not having expressed, after information, his opposition to the reuse of his data for the purposes of this research
- Exclusion Criteria:
- • Subject (and/or his parental authority) having expressed, after information, his opposition to the reuse of his data for the purposes of this research
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials